RecruitingNCT05402033

Cancer Clinical Trials Financial Reimbursement Program

Enhancement of Access to and Diversity in Cancer Clinical Trials Through a Financial Reimbursement and Outreach Program


Sponsor

University of Texas Southwestern Medical Center

Enrollment

1,200 participants

Start Date

Jul 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.


Eligibility

Inclusion Criteria2

  • Be enrolled in a therapeutic cancer clinical trial
  • Speak English or Spanish

Exclusion Criteria2

  • Not enrolled in a clinical trial
  • Does not speak English or Spanish

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSurvey / Interview Group

Patients with any cancer type who are informed that they may be eligible for participation in any phase therapeutic cancer clinical trial by their treating physician (typically a clinical oncologist) will be provided information about the Financial Reimbursement Program. Patients who enroll to therapeutic cancer clinical trial will be eligible for the reimbursement program and offered an opportunity to participate in this study.


Locations(1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05402033